Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS. Rosales RL, et al. Among authors: maisonobe p. Neurorehabil Neural Repair. 2012 Sep;26(7):812-21. doi: 10.1177/1545968311430824. Epub 2012 Feb 27. Neurorehabil Neural Repair. 2012. PMID: 22371239 Clinical Trial.
Factors influencing goal attainment in patients with post-stroke upper limb spasticity following treatment with botulinum toxin A in real-life clinical practice: sub-analyses from the Upper Limb International Spasticity (ULIS)-II Study.
Fheodoroff K, Ashford S, Jacinto J, Maisonobe P, Balcaitiene J, Turner-Stokes L. Fheodoroff K, et al. Among authors: maisonobe p. Toxins (Basel). 2015 Apr 8;7(4):1192-205. doi: 10.3390/toxins7041192. Toxins (Basel). 2015. PMID: 25856546 Free PMC article.
Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).
Turner-Stokes L, Ashford S, Jacinto J, Maisonobe P, Balcaitiene J, Fheodoroff K. Turner-Stokes L, et al. Among authors: maisonobe p. BMJ Open. 2016 Jun 17;6(6):e011157. doi: 10.1136/bmjopen-2016-011157. BMJ Open. 2016. PMID: 27315835 Free PMC article.
Poster 313 Relationship Between AbobotulinumtoxinA Injections into Shoulder Muscles and Patient Centred Primary Goal Selection and Achievement: Sub-Analyses from the Upper Limb International Spasticity (ULIS)-II Study.
Jacinto J, Balcaitiene J, Maisonobe P, Fheodoroff K, Ashford S, Turner-Stokes L. Jacinto J, et al. Among authors: maisonobe p. PM R. 2016 Sep;8(9S):S262. doi: 10.1016/j.pmrj.2016.07.483. Epub 2016 Sep 24. PM R. 2016. PMID: 27673067 No abstract available.
Effect of early use of AbobotulinumtoxinA after stroke on spasticity progression: Protocol for a randomised controlled pilot study in adult subjects with moderate to severe upper limb spasticity (ONTIME pilot).
Kong KH, Balcaitiene J, Berard H, Maisonobe P, Goh KJ, Kumthornthip W, Rosales RL. Kong KH, et al. Among authors: maisonobe p. Contemp Clin Trials Commun. 2017 Feb 14;6:9-16. doi: 10.1016/j.conctc.2017.02.004. eCollection 2017 Jun. Contemp Clin Trials Commun. 2017. PMID: 29740633 Free PMC article.
70 results